Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola

Olamide D Jarrett, Jane F Seward, Augustin E Fombah, Robert Lindblad, Mohamed I Jalloh, Jill El-Khorazaty, Peter Dawson, Deron Burton, Jane Zucker, Wendy Carr, Mohamed M Bah, Gibrilla F Deen, Peter M George, Faustine James, Durodami R Lisk, Dudley Pratt, James B W Russell, Jibao D Sandy, Patrick Turay, Mary J Hamel, Stephanie J Schrag, Robert E Walker, Mohamed Samai, Susan T Goldstein, Olamide D Jarrett, Jane F Seward, Augustin E Fombah, Robert Lindblad, Mohamed I Jalloh, Jill El-Khorazaty, Peter Dawson, Deron Burton, Jane Zucker, Wendy Carr, Mohamed M Bah, Gibrilla F Deen, Peter M George, Faustine James, Durodami R Lisk, Dudley Pratt, James B W Russell, Jibao D Sandy, Patrick Turay, Mary J Hamel, Stephanie J Schrag, Robert E Walker, Mohamed Samai, Susan T Goldstein

Abstract

ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Figures

Figure 1.
Figure 1.
Safety reporting for adverse events (AEs) and serious AEs (SAEs) in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj